Skip to main content
. 2017 May 21;23:2408–2425. doi: 10.12659/MSM.902032

Supplementary Table 5.

Multinomial logistic regression analysis of independent risk factors for developing of hospital-acquired and persistent dysnatremia.

Variable HA-hyponatremia HA-hypernatremia Persistent hyponatremia Persistent hypernatremia
OR(95%CI) P OR(95%CI) P OR(95%CI) P OR(95%CI) P
Age, per year increase 1.008 (1.006–1.010) 0.000 1.019 (1.013–1.024) 0.000 1.004 (1.002–1.006) 0.001
Male sex 1.182 (1.117–1.252) 0.000 0.692 (0.596–0.804) 0.000 1.258 (1.164–1.360) 0.000 1.274 (1.023–1.586) 0.030
BMI <18.5 kg/m2§ 1.811 (1.396–2.350) 0.000
BMI 25–27.99 kg/m2§ 1.297 (1.102–1.527) 0.002
BMI 28–32 kg/m2§ 1.269 (0.959–1.680) 0.096
Cancer 8.344 (7.640–9.113) 0.000 2.768 (2.173–3.525) 0.000
Pulmonary 1.449 (1.249–1.681) 0.000
Cardiovascular 1.279 (1.145–1.428) 0.000
Cardiothoracic surgery 13.330 (12.125–14.654) 0.000 10.989 (9.009–13.403) 0.000 1.416 (1.270–1.580) 0.000
Digestive 1.651 (1.432–1.903) 0.000
Endocrine 2.187 (1.465–3.263) 0.000
General surgery 4.042 (3.670–4.452) 0.000 1.843 (1.429–2.376) 0.000
Hematological 1.532 (1.280–1.834) 0.000
Neurological 2.575 (2.185–3.035) 0.000 6.007 (4.586–7.868) 0.000
Gynecology 3.084 (2.565–3.708) 0.000 1.741 (1.330–2.279) 0.000
Orthopedic surgery 1.360 (1.128–1.640) 0.001
SBP>140 mmHg 1.359 (1.111–1.661) 0.003
DBP <60 mmHg§ 1.546 (1.304–1.834) 0.000 2.330 (1.657–3.276) 0.000
Glucose 5.7–10 mmol/L§ 1.133 (1.071–1.198) 0.000
Glucose >10 mmol/L§ 1.319 (1.163–1.496) 0.000
Hypokalemia 2.169 (1.769–2.659) 0.000
Hypochloremia§ 2.064 (1.874–2.273) 0.000 1.420 (1.308–1.540) 0.000
Hyperchloremia 1.868 (1.234–2.826) 0.003
Hypocalcemia 1.460 (1.344–1.586) 0.000 1.650 (1.347–2.021) 0.000
Hypomagnesemia 1.917 (1.492–2.464) 0.000 1.929 (1.107–3.362) 0.020 1.579 (1.124–2.217) 0.008
Hypermagnesemia 1.504 (1.174–1.928) 0.001
Hypophosphatemia 1.142 (1.052–1.240) 0.002 1.818 (1.484–2.228) 0.000
Hyperphosphatemia 1.242 (1.137–1.357) 0.000
CO2CP <23 mmol/L§ 1.230 (1.155–1.310) 0.000
AG >16 mmol/L§ 1.293 (1.199–1.394) 0.000 1.558 (1.298–1.870) 0.000 1.370 (1.069–1.755) 0.013
ALT, per 50 U/L increase 1.015 (1.001–1.030) 0.041
TBIL, per 20 μmol/L increase 1.087 (1.066–1.108) 0.000 1.102 (1.059–1.147) 0.000 1.031 (1.013–1.050) 0.001
Albumin, per 5g/L decrease 1.275 (1.234–1.318) 0.000 1.458 (1.347–1.578) 0.000
Hemoglobin (90–119 g/L)§ 1.161 (1.090–1.237) 0.000 1.179 (1.087–1.280) 0.000
Hemoglobin (60–89 g/L)§ 1.471 (1.307–1.656) 0.000 1.277 (1.119–1.457) 0.000
Hemoglobin (<60 g/L)§ 1.713 (1.303–2.252) 0.000 1.233 (0.929–1.638) 0.147
WBC <4.0×109/L§ 1.142 (1.025–1.273) 0.016
WBC >12.0×109/L§ 1.556 (1.378–1.758) 0.000 2.322 (1.805–2.987) 0.000
BUN, per 10 mg/dl increase 1.107 (1.066–1.149) 0.000 1.238 (1.149–1.334) 0.000
SCr, per 0.5 mg/dl increase 0.958 (0.926–0.990) 0.011
Hypouricemia§ 1.084 (1.003–1.170) 0.041
Hyperuricemia§ 1.135 (1.046–1.231) 0.002 1.481 (1.212–1.810) 0.000 1.132 (1.012–1.267) 0.031

Normonatremia served as the reference for HA-dysnatremia and improved dysnatremia as the reference for corresponding persistent dysnatremia. For underlying diseases, the rest of the other patients served as the references.

§

Normal range as the reference.

BMI – body mass index; SBP – systolic blood pressure; DBP – diastolic blood pressure; CO2CP – carbon dioxide combining power; AG – anion gap; ALT – alanine aminotransferase; TBIL – total bilirubin; WBC – white blood cell; BUN – blood urea nitrogen; SCr – serum creatinine; OR – odds ratio; CI – confidence interval.